Tolerance Bio
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$20.2M
Tolerance Bio, Inc. is a biopharmaceutical company developing thymus-based therapies and iPSC-based cell treatments for immune-mediated diseases like cancer, autoimmunity, and transplant rejection.
Focus Areas
Biopharmaceutical
thymus-based therapies
immune-mediated diseases
iPSC-based cell therapies
pharmacological treatments
cancer
Investors
